Victory Capital Management Inc. Makes New Investment in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Victory Capital Management Inc. purchased a new position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Rating) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 12,062 shares of the company’s stock, valued at approximately $128,000. Several other institutional investors also recently added to or reduced their stakes in […]
Back
Read News